This capacity was demonstrated by Wuthrich and Rubin-Kelley and their collaborators for virus-transformed mouse proximal tubule cells [2, 3] , by Hagerty and Allen for primary cultures of mouse proximal tubules cells [4] , and by Mendrick, Kelly and Rennke for passaged rat glomerular epithelial and mesangial cells [5] .
Cell-mediated immune mechanisms have long been suspected of playing a role in the pathogenesis of allograft rejection, drug-induced interstitial nephritides, and some forms of glomerulonephritides in humans. Direct confirmation that such a mechanism is responsible for the acute interstitial inflammation seen in patients after exposure to a drug or other exogenous substances is still largely missing [6] . The extensive studies by
Neilson and Kelly and collaborators on murine models of spontaneous autoimmune interstitial nephritis [7] [8] [9] [10] [11] [12] [13] [14] [15] and those by Wilson et al [16] [17] [18] and Neilson et al [19] [20] [21] [22] on the anti-tubular basement membrane disease in Brown Norway rats clearly suggest that tubulointerstitial damage can occur in the context of an altered autoimmunity. Likewise, in some forms of glomerular injury, where the formation of cellular crescents dominates the morphological expression of the disease, a predominance of monocytes and macrophages has also led to postulate a cell-mediated process. The only model studied in detail to date that involves an exogenous antigen is the accelerated nephrotoxic serum nephntis in the rat. Although most rat strains do not develop overt crescents in this experimental model, Schreiner et al described the participation of monocytes during the early cellular events [23, 24] , and Bhan et al [25, 26] and Holdsworth et al [27] [28] [29] [30] were able to document the participation of T cells in the pathogenesis of this form of glomerular injury.
In the present studies, we set out to establish a model of cell-mediated injury to a relatively well-studied hapten with the aim of determining the mechanisms of cell injury, the type of cells and mediators involved, and the structural and functional expression of this process. In this model we used azobenzenearsonate (ABA), a hapten that can be introduced directly into cell surface components of potential target cells [31] [32] [33] [34] , thereby bypassing the step of intracellular antigen processing and subsequent re-expression of epitopes in the context of products of the major histocompatibility complex [35] [36] [37] [38] [39] [40] [41] [42] [43] . Our studies indicate that resident kidney cells have the capacity to present an exogenous antigen such as ABA and that the 1044 resultant disease process has all the characteristics of a delayed type hypersensitivity.
Methods

General experimental design
The experiments were designed to demonstrate a role for cell-mediated immunity and, in particular, a role for delayed type hypersensitivity (DH) in the pathogenesis of inflammatory renal processes in the Brown Norway rat. In these studies, we cross linked ABA directly to the renal parenchyma by intraarterial perfusion of the left kidney with diazotized arsaniic acid. This procedure introduces haptenic groups onto multiple cell surface molecules and obviates the need for complex intracellular antigen processing steps. The immune response and the renal injury were studied at various time intervals in control rats and animals pre-immunized with the hapten conjugated to a carrier protein. The expression of a disease process mediated exclusively by antibodies directed against ABA was studied by passive administration of hyperimmune rat serum to a separate group of animals with planted ABA. The participation of cell-mediated immune processes was verified by adoptive transfer of T cells obtained from the lymph nodes of Benzenearsonate diazonium (40 mM) was prepared as described by Bach et at [31] . For this purpose, 241 mg paraArsaniic acid (Eastman Kodak Co., Rochester, New York, USA) was solubilized in 24 ml of distilled water by the addition of 3 ml of 1 N HC1. Diazotization was carried out by dropwise addition of 0.8 ml of NaNO2 solution, 10 g/100 ml (Fisher Scientific Co., Fair Lawn, New Jersey, USA). This amount was, in general, sufficient to demonstrate free nitrite in the solution by the instantaneous color change of potassium iodidestarch paper (Fisher Scientific Co.). The solution was kept at room temperature for 15 minutes and was re-tested for free nitrite at the end of this reaction time. The diazotized arsanilic acid was then placed under vacuum and used within four hours. For intra-arterial perfusion of the left kidney, 4 ml of a 4 mM solution of ABA was prepared by 1:10 dilution in borate buffered saline (BBS; pH 8.40) and the final pH adjusted between 8.1 and 8.2 with a pre-measured amount of 1 N NaOH. A volume of 2 ml of this solution was immediately perfused into the left kidney as described below.
Coupling of ABA to carrier proteins p-Arsanilic acid (34.1 mg) was dissolved in 2.5 ml of I N HCI and completely diazotized by slow, incremental addition of 1.3 ml of freshly prepared aqueous NaNO2, I g/100 ml. The reaction was performed on ice. Keyhole limpet hemocyanin (KLH) was obtained from Calbiochem Corp. (La Jolla, California, USA); 500 mg of the protein was resuspended in 20 ml of BBS on ice and the pH adjusted to 9.2 by addition of 1 N NaOH. The diazotized arsaniic acid was then added slowly over five to seven minutes, while the pH was maintained between 9.0 and 9.3 by the addition of 1 N NaOH. The reaction mixture was stirred for an additional 60 minutes and dialyzed for 48 hours against phosphate buffered saline (PBS; NaC1 9 glliter, 5 mri sodium phosphate buffer, pH 7.4). A similar protocol was used for coupling ABA to other proteins.
Immunization of animals and preparation of anti-ABA antiserum
Rats were immunized by a subcutaneous injection, in the lower back at the root of the tail, with I mg ABA-KLH emulsified in 0. 35 . An immunoglobulin fraction was isolated with 50% saturated ammonium sulfate, resuspended in PBS at a final volume identical to the initial amount of serum, and extensively dialyzed against PBS.
Measurement of DH to ABA in vivo
Animals immunized with ABA-KLH in CFA or control rats that had received bovine serum albumin (BSA) in CFA were challenged at various time points for determination of DH to the hapten. We adapted the procedure of footpad challenge described by Bach et al for the mouse [31] . For this purpose, pre-injection measurements of both hind leg footpads were performed with an Mitutoyo engineer's caliper calibrated in 1/100 mm (Harbor Tool Supply, Westwood, Massachusetts, USA). Left and right hind legs were then injected randomly with either 50 p.! of 10 m activated ABA in BBS or 50 p.1 of BBS alone. The magnitude of the DH reaction was then expressed as the increment in footpad thickness, a value that can be compared to the contralateral measurement or to the reaction in control animals immunized with BSA in CFA. Other immunized animals were also challenged with an irrelevant antigen which was used as a specificity control. All values were the average of triplicate measurements performed without knowledge as to the type of injection in any given footpad or as to the immune status of the animal.
Histologic changes in the footpads were assessed following standard light microscopic techniques. Assessment of DH to ABA in vitro by T cell proliferation assay The capacity of T cells to proliferate in response to antigen presenting cells exposed to ABA was determined by 3H thymidine incorporation using a method modified from Neilson et al [20] and Ulich, Bannister and Wilson [44] . Briefly, cells harvested from draining lymph nodes of animals immunized 10 days earlier with ABA-KLH in CFA or CFA alone were depleted of B cells by indirect panning with rabbit anti-rat immunoglobulin antibodies [45] and resuspended in RPMI 1640 containing 2 mrvi L-glutamine, 10 mtt HEPES, 5 X l0 M 2-mercaptoethanol, and 5% fetal calf serum. Assessment of the humoral response Antibody titers were determined by solid phase RIA in microtiter plates. For this purpose, round-bottomed microwell polyvinyl chloride plates (Dynatech Laboratories, Inc., Chantilly, Virginia, USA) were coated overnight at 4°C with 10 zg/m1 ABA-BSA in a Na2CO3/NaHCO3 buffer, pH 9.6, washed with PBS-Tween, and incubated for two hours in a humidified chamber at room temperature with increasing dilutions of serum in PBS containing ovalbumin (0.5 gIlOO ml). Following repeated washings, the wells were incubated with '251-labeled rabbit anti-rat immunoglobulin (2 x l0 cpm!well) for two hours, washed repeatedly, and the bound radioactivity determined with a y counter. A positive titer at any given dilution was defined as a value equal or greater than 3 X background radioactivity obtained with pre-immune rat serum at a similar dilution.
A solid-phase ELISA system was used to evaluate the isotype class response against ABA. Plates were coated with ABA-BSA and incubated with rat serum as described above. The plates were washed and incubated with either horseradish peroxidase labeled sheep anti-rat IgG (The Binding Site, San Diego, California, USA) or rabbit anti-rat 1gM (Zymed Laboratories, South San Francisco, California, USA). The bound secondary antibodies were visualized using o-phenylenediamine, and the reaction was measured spectrophotometrically at a wavelength of 492 nm using a Bio-Tek EL3 11 automatic plate reader with KinetiCaic 2.03 software (Bio-Tek Instruments, Inc., Winsooki, Vermont, USA). A positive titer was defined as the dilution at which the 0D492 was at least 0.1 units greater than that obtained with a normal rat serum at a similar dilution. Using purified rat immunoglobulins from Zymed Laboratories in a solid phase ELISA, we found that the sheep anti-rat IgG preparation recognized all rat IgG subclasses and, to some extent, 1gM. The rabbit anti-rat 1gM reagent was specific for 1gM. Thus, the antibody response information is presented as titers of 1gM and IgG + 1gM.
Active disease model
Brown Norway rats were pre-immunized with either ABA-KLH in CFA or with CFA alone. Ten days after the primary immunization, the left kidney was perfused through the renal artery successively with 1 to 2 ml PBS containing 0.05 mg/ml verapamil, 2 ml of freshly activated ABA (4 m solution in borate buffered saline solution at pH 8.1), and 1 ml of PBS! verapamil. For this purpose, the left renal vessels were identified and isolated. A loose snare was placed around the left renal vein and the abdominal aorta, between the superior mesenteric artery and the left renal artery. The left renal artery was then canulated with a 30 gauge needle, while the snares around the aorta and the renal vein were closed. Ex vivo perfusion occurred at a constant flow rate of 1.1 mI/mm. The effluent was drained through a puncture of the temporarily ligated left vein to minimize exposure of other organs and blood elements to the hapten. Re-perfusion occurred promptly within one to two minutes after release of ligatures and hemostasis. The total ischemia time to abdominal organs was less than 12 minutes. Animals were sacrificed after 4, 24, 48, and 120 hours after intraarterial perfusion with the hapten. The left (ABA-perfused) and right (non-perfused) kidneys were processed for standard immunofluorescence, light, and electron microscopy, as described previously [46, 47] . Fluorescein-labeled antibodies against ABA, rat IgG, and rat C3 were utilized for direct immunofluorescence microscopy. Infiltrating inflammatory cells were identified by standard peroxidase-immunohistochemistry as described previously [48] . Briefly, coronal kidney sections were frozen in liquid nitrogen and sectioned in a cryostat at 4 to 6 m. Sections were fixed in acetone for 10 minutes, washed in PBS, and incubated for one hour with the optimally diluted primary monoclonal antibody. Sections were washed repeatedly and incubated with peroxidase-conjugated rabbit anti-mouse IgG (Dako Corp. Santa Barbara, California, USA) diluted appropriately in PBS. Peroxidase activity was detected using H202 and diaminobenzidine (DAB, 6 mg/ml in 0.1 M Tris!saline buffer at pH 7.6 containing 0.03% H202).
Sections were washed, lightly counterstained with hematoxy-T cell subsets and against monocyte/macrophages. OX-8 (spelin, dehydrated, cleared, and mounted in synthetic resin. We cific for suppressor T cells) and W3/25 (recognizing T helper utilized unlabeled mouse monoclonal antibodies against various cells) were a gift from Dr. Alan F. Williams (University of Oxford, Oxford, UK). R73, a monoclonal antibody directed against the a,f.-T cell receptor produced by Hunig et a! [49] , was provided by Dr. Edgar Milford (Boston, Massachusetts, USA). EDI, which recognizes rat monocytes/macrophages [501, was purchased from Bioproducts for Science (Indianapolis, Indiana). The frequency of each subset of infiltrating inflammatory cells was estimated semiquantitatively on mid-coronal sections of the kidney.
The extent of cortical renal tissue involved by the inflammatory infiltrate was estimated by planimetry on standard paraffin sections stained with hematoxylin and eosin, utilizing a computerized morphometric unit (Zeiss Videoplan, Carl Zeiss Inc., New York, NY, USA). For this purpose, two whole mount coronal sections of each right and left kidneys were photographed at low magnification, and the renal cortex and the areas of active inflammation were identified under light microscopic examination at medium power and mapped onto the photo- For these experiments, animals were injected with CFA alone 10 days earlier, and their left kidneys were perfused with ABA as described above. One group of animals received a single dose of high-titered antibody preparation (1 ml i.v., titer 1:65,536) one hour following the perfusion procedure. Animals were sacrificed either 3 or 120 hours following antibody administration. A second group of experimental animals received antibodies on four consecutive days (1 ml i.v./day) and were sacrificed on day five. Structural studies were performed as described above.
Results
Active disease model in the kidney
Following perfusion of the left kidney with activated ABA under the conditions described above, the hapten was found to bind uniformly to the elements of the glomerular capillary wall, peritubular capillaries, tubule cell surfaces, and tubular basement membranes when analyzed by direct immunofluorescence microscopy with rabbit anti-ABA antibodies (Fig. 1, A and B) . The non-perfused right kidney did not show ABA reactivity. After ABA perfusion, control CFA animals showed minimal cortical abnormalities (Fig. 1C) , with occasional foci of tubular necrosis that, on day 5, appeared as small areas of interstitial widening and minimal inflammation (not illustrated). Quantitative assessment by planimetric measurement of such areas on day 5 revealed an average of 8.1 3.8% (N = 10 rats) of cortical tissue involved by such damage. These lesions tended to resolve over the following two weeks with reduction of the involvement to 3.4 0.9% by day 12 (N = 9 rats), This damage was felt to represent ischemic injury of the perfusion process since similar damage could be reproduced by temporary ligation of the left renal artery for 15 to 30 minutes.
However, in animals pre-immunized with ABA-KLH in CFA, direct coupling of ABA to the left kidney resulted, by 24 hours, in a mild but rather diffuse inflammatory cell infiltration of the interstitium and glomeruli. The infiltrate was composed predominantly of polymorphonuclear leukocytes, lymphocytes, and other mononuclear inflammatory cells. The inflammatory infiltrate became much more intense and mononuclear in character in the following days. By day 5, the process was distinctly granulomatous, with massive destruction of cortical elements by an infiltrate composed predominantly of epithelioid and giant cells (Fig. lD) . Isolated areas in some animals were spared by this inflammation, presumably due to uneven and incomplete delivery of the hapten to such areas during the perfusion procedure. An average of 71.5 5.2% (N = 22 rats) of the cortical area was involved by the granulomatous inflammatory process. Structural abnormalities in glomeruli included intracapillary hypercellularity, crescent formation, and periglomerular granulomatous reactions (Fig. 1E) . Binding of rat immunoglobulins or complement was minimal within glomeruli and undetectable at the level of the tubulointerstitial compartment when examined by direct immunofluorescence microscopy (Fig. IF) . The right unperfused kidney remained histologically normal.
Immunohistochemistry was performed on frozen sections to determine the phenotype of infiltrating cells. The results are summarized in Table 1 . Within two hours of the planting of ABA into the left kidney of pre-immunized rats, small numbers of R73 + (cells bearing the a,/3 T cell receptor) were identified in the early infiltrate. Several W3/25+ cells (T helper/inducer cells, macrophages, thymocytes) and OX8+ cells (cytotoxic/ suppressor T cells, NK cells, thymocytes) were identified as well; a few monocytes/macrophages (ED! +) were also present. By 24 hours, the R73 + cells had increased modestly, and the predominant cell type was the monocyte/macrophage. The infiltrate was also enriched in OX8 + and W3/25 + cells at this time. The inflammatory infiltrate became much more diffuse and intense over the following three days, with a great preponderance of ED1 + monocytes/macrophages by day 5.
Significant proteinuria did not develop in these animals.
Serum levels of creatinine and urea nitrogen were not measured since we did not anticipate noticeable changes in this unilateral model of interstitial disease. Infiltrating cells were characterized by peroxidase-immunohistochemistry utilizing the following monoclonal antibodies: R73, which recognizes the a,$ subunit of the T cell receptor, W3/25, which recognizes helper T cells, 0X8, which recognizes suppressor T cells and NK cells, and ED 1, specific for monocytes/ macrophages. The frequency of cells reactive with any particular antibody is indicated semiquantitative in a scale from 0 to ++++. The results of the in vivo assessment of DH by footpad swelling are summarized in Table 2 . Six to eight days following immunization, the response to the hapten produced a moderate and somewhat inconsistent increase in footpad thickness when measured 24 hours after the challenge. No significant swelling occurred in vehicle injected contralateral footpads (differences of <10 x 10-2 mm), after challenge with an irrelevant antigen-(data not shown), or after ABA challenge in animals immunized with CFA alone (<20 x 10-2 mm). The degree of swelling increased substantially in animals challenged on days 9 to 10 after immunization, reaching a peak of 220 13 x 10-2 mm between days 11 and 14. As expected of a cell-mediated response, the footpad swelling increased from 93 14 x 10-2 mm at day I after challenge to 129 13 x l0_2 mm on day 2 in a separate group of animals tested on day 10 and followed for 48 hours.
Light microscopic assessment of footpads revealed a striking perivascular leukocyte infiltration of the dermis and sub-dermal tissues at the injection site 24 hours after the challenge, followed, at 48 hours, by a characteristic granulomatous inflammation (Fig. 2) .
In vitro T cell proliferation as a measurement of DH response to ABA
The results of these studies are summarized in Table 3 . Reactive cells were obtained from draining lymph nodes 10 days following immunization with ABA-KLH in CFA or control immunizations with CFA alone. T cells were depleted of B cells by negative panning with rabbit anti-rat immunoglobulin antibodies and incubated with various antigenic preparations.
Concanavalin A (Con A) stimulated T cell proliferation peaked as early as day 3 in culture, as observed previously by other investigators, while antigen-specific proliferation (ABA-BSA and ABA-KLH) was maximal at days 4 or 5. Note the lack of proliferation to the protein carrier BSA. In conjunction with the in vivo footpad challenge data, these results indicate that the rat is capable of developing a cell-mediated, delayed type hypersensitivity to the hapten ABA.
Antibody response following ABA-KLH immunization The titers of antibodies against ABA that developed in rats at various times following active immunization with ABA-KLH are graphically depicted in • .. ,,.. -.
-i"r"tç -:c:c following T cell transfer was reported by other investigators working with rat models of autoimmune renal disease [18] . Passive administration of high titered rat anti-ABA antibody preparation (1 ml of an Ig preparation, 1 hr after ABA perfusion) resulted in minimal glomerular hypercellularity at three hours or five days, at times when rat IgG was bound in a linear pattern along the glomerular capillary wall (+ + +14+) and the tubular basement membranes (+14+) (Fig. 5A) . No significant class. In comparison, pre-immune titers are undetectable and the hyperimmune serum (5 weeks after immunization with ABA-KLH in CFA followed by two additional booster subcutaneous immunizations of the immunogen in incomplete adjuvant on days 14 and 28) reveals a titer of >6. The antibody titer depicted on the y axis is expressed as the -log10 of the dilution that resulted in greater than 3 x background counts.
inflammation was noted in these rats, but foci of tubular atrophy with mild interstitial edema were observed by day 5 (N = 4).
When the passive administration of anti-ABA antibodies was increased to 1 ml on four consecutive days (N = 3), small foci of tubular dilatation and atrophy were again present, involving 25.8 9.6% of the cortex at day 5. The lesions were confined predominantly to S3 segments and to the tubules within the columns of Bertin. However, this level of passive antibody administration also resulted in glomerular injury with a distinct diffuse endocapillary proliferative pattern and focal and segmental necrotizing glomerulitis (Fig. 5 B and C) . Direct immunofluorescence microscopy showed strong rat IgG and weak C3 binding to all basement membranes, in particular to the GBM, peritubular capillaries, and tubular basement membranes, a finding never observed in the active disease model. This strong antibody binding, the presence of a diffuse endocapillary proliferative and necrotizing glomerulitis, and the absence of granulomatous lesions in animals with passive antibody administration clearly distinguishes this antibody-mediated process from the disease induced in actively immunized animals or in animals with adoptive transfer of immune cells. The nature of the mild tubulointerstitial damage seen in some animals that were given antibodies could be mediated by classic antibody and complement-dependent processes, however, the similarities with the lesions induced by transient ischemia to the kidney are rather striking.
Discussion
These experimental studies were designed to investigate a potential role of cell-mediated immune reactions to planted, 28 exogenous antigens or haptens in the development of renal injury. Although cell-mediated processes have been assumed to play key roles in the pathogenesis of antibody-independent renal diseases in man, reliable experimental models that faithfuliy duplicate the structural and functional abnormalities of the human conditions that sometimes ensue after re-exposure to an exogenous antigen have not been developed. Our studies were designed to demonstrate that constitutive cells of the renal cortex can serve as targets for delayed type hypersensitivity. These initial studies used an exogenous antigenic determinant that does not require an intracellular processing step. To this effect, our studies do not address directly the issue of cellular uptake and intralysosomal processing of the antigen by renal cells. Instead, we chose to focus first on the ability of the kidney to become the target for ABA-specific T cells. We chose azobenzenearsonate, a hapten used extensively in murine studies of the immune system. The immune response to this hapten in the Brown Norway rat was evaluated at various levels. The ability of such animals to mount a specific DH response was assessed quantitatively and morphologically in the footpad of after ABA perfusion. T lymphocytes, obtained from previously immunized rats, exhibited antigen-specific proliferation in vitro, and such cells were capable of transferring a similar disease modality to naive rats in which ABA had been planted in the left kidney. Although we have not explored in detail a possible special strain susceptibility to ABA in the Brown Norway rat, there is little evidence in the literature that would suggest that this strain reacts to ABA immunization in any special way.
Although differences in susceptibility in rat strains to develop a particular tissue response have been described, such genetic factors have mainly been explored for the process of focal glomerulosclerosis [52] and for antibody-dependent reactions [53] . We have been able to replicate the foot pad reaction to ABA in immunized rats of several strains (data not included).
Additional experiments were designed to determine if ABAspecific antibodies could play a pathogenic role in this disease model. Radioimmunoassays revealed a minimal 1gM response to ABA 10 days following immunization. Such large immunoglobulin molecules are known to have limited access to renal structures [51] , and this was reflected in the lack of demonstrable binding of rat immunoglobulins in the glomeruli of animals undergoing an active disease. To further investigate the pathogenicity of anti-ABA antibodies, passive transfer experiments were conducted. Antibodies were obtained from serum of hyperimmunized rats and, in this preparation, most of the anti-ABA activity was found in the IgG class. The antibody was administered to naive animals in which ABA had been planted in the left kidney. Unlike the active model in which minimal immunoglobulin was bound to renal structures, passive administration of anti-ABA IgG resulted in the diffuse binding of rat antibody to the renal basement membranes. The animals, however, did not develop a granulomatous inflammation but did exhibit a proliferative glomerular injury with focal necrotizing glomerulitis ; such injury was not seen in the active disease model. These studies suggest that antibodies alone played a minor, if any, role in the granulomatous interstitial nephritis seen in the active disease. We cannot rule out completely a potentially permissive or synergistic role of antibodies in the pathogenesis of the active disease model since the actively immunized animals clearly responded to the ABA challenge with a more aggressive and extensive injury to the kidney.
Additional unexplored mediator systems may be up-regulated in this setting and may play a critical role in the heightened inflammatory response seen in the active model.
The model of renal injury describe by us utilizes a hapten which was directly coupled to cell surface determinants, thus most likely eliminating the need for intracellular processing of crescents were also observed. Phenotypic characterization of antigen and re-expression of epitopes on the cell surface in the the infiltrating cells demonstrated that both T cells and macro-context of MHC antigens. These studies demonstrated that phages begin to accumulate in the renal cortex within two hours renal structures can serve as targets of a cell-mediated immune sangial cells have the capacity to process and present complex antigens to T cell hybridomas [5] . Tubular cells in culture have also been shown to have the capacity to process and present complex antigens [2] [3] [4] .
Over the past few years, several investigators have reported on the antigen presenting capacity of several non-lymphoid cell types originally not thought of as having this function. To this effect, Pober and colleagues were able to show that cultured endothelial cells can up-regulate class II MHC antigens under the influence of interferon-y and act effectively in antigen presentation [54] [55] [56] [57] [58] . Others have also shown similar MHC antigen responses to cytokines and immune regulatory capacity for epithelial cells derived from the intestine [59] [60] [61] [62] [63] , the thyroid gland [64] [65] [66] [67] , pancreatic 13 cells [68] , the thymus [69, 70] , and the skin [71] [72] [73] [74] . Although many of these studies were performed on cultured cells and used relatively unregulated T cell hybridomas or cells from cloned T cell lines and could be criticized on this basis, our current studies clearly suggest that such processes also occur in the intact animal. It is difficult to prove, in this setting, that the primary antigen presentation event is initiated by tubular epitheial cells and cells intrinsic to the glomerular microcirculation since professional antigen-presenting cells, such as macrophages, are always present in the renal parenchyma. These studies, viewed in the context of the previously quoted cell culture experiments, strongly suggest an antigen presenting capacity for kidney cells other than professional macrophages.
The ABA-induced nephritis described here represents the first attempt to model acute interstitial nephritis seen in humans, a process in which, as a rule, the participation of antibodies or immune complexes has only rarely been documented. Such an inflammatory process is often the consequence of an exposure to therapeutic agents such as antibiotics, non-steroidal anti-inflammatory agents, or other drugs. Most often this tissue reaction in humans involves a mononuclear cell infiltration of the tubulointerstitial compartment, however, occasionally a granulomatous inflammation is seen instead, as in our model system. The precise mechanisms and mediator systems responsible for either a lymphocytic or a granulomatous tissue response are currently only incompletely explored.
Differences in the type of T cells elicited after the active immunization, variations in the capacity of the target cells to attack, although the precise Identity 01 tne initiating antigen-express or up-regulate certain histocompatibiity molecules, presenting cell in this model remains currently undetermined, and other local factors may be responsible for this variability in We have previously shown that glomerular epithelial and me-the tissue expression. The capacity of the kidney to concentrate the ultrafiltrate and the presence of various transport systems within the tubule cells may result in drug concentrations within intrinsic renal cells that could exceed that seen in other organs by orders of magnitude. The kidney, therefore, becomes an ideal candidate for toxic and potentially immune-mediated injury. Patients with drug-induced acute interstitial nephritides are usually afflicted by a disease that may have systemic symptoms but with an inflammatory reaction that is limited to the kidney. If this reaction were exclusively triggered by professional antigen presenting cells without the participation of intrinsic renal cells one would expect to find cell-mediated immune reactions and an accompanying mononuclear cell inflammation in areas of the body particularly rich in antigen presenting cells and not just an inflammation limited to the tubules and the interstitial area. This observation, together with the evidence provided by our studies, suggests that the kidney offers a unique environment for immune-mediated reactions. We propose that the concentrating function of the kidney and potentially an immune-modulatory and an antigen presenting capacity of intrinsic renal cells contribute significantly to the observed propensity of the kidney to be involved in druginduced and cell-mediated inflammatory disease processes.
